SYSTEMATIC REVIEW
Accepted on 15 Jul 2025
Cost-Effectiveness of Chemotherapy for Advanced and Recurrent Cervical Cancer: A Systematic Review
doi 10.3389/frhs.2025.1616223
- 104 views
- Frontiers in Immunology
- Cancer Immunity and Immunotherapy
- Research Topics
- Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
Streamlining Drug Approvals: Addressing Policy Challenges in Genitourinary Oncology
1,061
Total downloads
4,811
Total views and downloads
Submit your idea
Select the journal/section where you want your idea to be submitted:
Articles
REVIEW
Accepted on 11 Jul 2025
Development and landscape of maintenance therapy after first-line treatment of advanced or metastatic urothelial carcinoma
doi 10.3389/fimmu.2025.1541213
- 127 views
REVIEW
Published on 25 Jun 2025
Changing landscape of first-line treatment for locally advanced or metastatic urothelial carcinoma: the progression from platinum-based chemotherapy to platinum-free therapy
doi 10.3389/fimmu.2025.1604395
- 694 views
ORIGINAL RESEARCH
Published on 09 Sep 2024
Cost-effectiveness of first-line enfortumab vedotin in addition to pembrolizumab for metastatic urothelial carcinoma in the United States
doi 10.3389/fimmu.2024.1464092
- 2,818 views
- 6 citations
Published in
Frontiers in Immunology
Cancer Immunity and Immunotherapy
Participating Journals
Frontiers in Health Services
- 2.7 impact factor
- 2.5 citescore
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore
Manuscripts can be submitted to this Research Topic via the main journal or any other participating journal.
Submit your idea
Select the journal/section where you want your idea to be submitted: